The Calcitonin and Glucocorticoids Combination: Mechanistic Insights into Their Class–Effect Synergy in Experimental Arthritis

Open Access

Peer-reviewed

Research Article

Adam Al-Kashi,

Affiliation The William Harvey Research Institute, Barts and The London School of Medicine, London, United Kingdom
⨯
Trinidad Montero-Melendez,

Affiliation The William Harvey Research Institute, Barts and The London School of Medicine, London, United Kingdom
⨯
Niloufar Moradi-Bidhendi,

Affiliation The William Harvey Research Institute, Barts and The London School of Medicine, London, United Kingdom
⨯
James P. Gilligan,

Affiliation Tarsa Therapeutics, Philadelphia, Pennsylvania, United States of America
⨯
Nozer Mehta,

Affiliation Unigene Corporation, Fairfield, New Jersey, United States of America
⨯
Mauro Perretti

* E-mail: m.perretti@qmul.ac.uk

Affiliation The William Harvey Research Institute, Barts and The London School of Medicine, London, United Kingdom
⨯

Reader Comments (0)

Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Arthritis
Is the Subject Area "Arthritis" applicable to this article?

Thanks for your feedback.
Skeletal joints
Is the Subject Area "Skeletal joints" applicable to this article?

Thanks for your feedback.
Collagens
Is the Subject Area "Collagens" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Glucocorticoid therapy
Is the Subject Area "Glucocorticoid therapy" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.